Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Mott David M
Relationship:   Director
City:   Gaithersburg
State:   MD
   
Insider Summary:
  
   
Companies Owned :   36    
Direct Shares   6,113,369    

Indirect Shares

   266,283,930      
Direct Value   $8,965,725    

Indirect Value

   $986,970,198      
Total Shares   272,397,299      
Total Value   $995,935,923      


Ardelyx Inc $7,690,174 Mersana Therapeutics, Inc. $1,259,805 Cloudflare, Inc. $0 Novavax Inc $15,746 Enliven Therapeutics Ord Shs $0 Ardelyx Inc $7,690,174 Mersana Therapeutics, Inc. $1,259,805 Cloudflare, Inc. $0 Novavax Inc $15,746 Enliven Therapeutics Ord Shs $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    10   
    0    

     Stock price went up :
    4   
    0    
     Stock price went down :
    6   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   23.6%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Medimmune Inc MEDI Vice Chairman, CEO & P... 2007-06-01 0 2003-09-15 0    Premium*  
            Clovis Oncology, Inc. CLVS 10% Owner 2011-11-21 0 2013-06-03 575    Premium*  
            Millennial Media Inc MM 10% Owner 2012-04-03 0 2012-10-29 8,196,614    Premium*  
            Tesaro, Inc. TSRO Director, 10% Owner 2019-01-22 0 2019-01-22 0    Premium*  
            Workday, Inc. WDAY 10% Owner 2013-04-09 0 2013-04-09 1,171    Premium*  
            Interleukin Genetics Inc ILIU 10% Owner 0 2016-07-29 55,418,811    Premium*  
            Epizyme, Inc. EPZM Director 2022-08-12 0 2022-08-12 0    Premium*  
            Care.com Inc CRCM 10% Owner 2014-01-29 0 2017-11-06 2,302    Premium*  
            Roka Bioscience, Inc. ROKA 10% Owner 0 2014-07-22 3,216,810    Premium*  
            Loxo Oncology, Inc. LOXO 10% Owner 2014-08-06 0 2014-08-06 1,789,420    Premium*  
            Box Inc BOX 10% Owner 0 2015-01-28 0    Premium*  
            Tracon Pharmaceuticals, Inc. TCON 10% Owner 2015-02-04 0 2016-11-29 2,758,039    Premium*  
            Champions Biotechnology Inc CSBR 10% Owner 0 2015-03-11 18,750,000    Premium*  
            Ardelyx Inc ARDX Director 2023-06-15 1,192,275 2019-12-09 6,564,372    Premium*  
            Nuvelo Inc ABIO 10% Owner 0 2018-02-26 0    Premium*  
            Synlogic Inc SYBX 10% Owner 2015-10-05 0 2018-01-26 4,228,940    Premium*  
            Avalo Therapeutics, Inc AVTX 10% Owner 2015-10-20 0 2015-10-20 594,245    Premium*  
            Adaptimmune Therapeutics PLC ADAP Director, 10% Owner 0 2020-01-24 102,478,668    Premium*  
            Aveo Pharmaceuticals Inc AVEO 10% Owner 0 2019-04-08 25,243,865    Premium*  
            Achaogen Inc AKAO 10% Owner 0 2016-12-19 5,215,128    Premium*  
            Ra Pharmaceuticals, Inc. RARX 10% Owner 2016-10-31 0 2016-10-31 3,490,073    Premium*  
            Cascadian Therapeutics, Inc CASC 10% Owner 0 2018-03-09 0    Premium*  
            Mulesoft, Inc MULE 10% Owner 0 2018-05-01 0    Premium*  
            Mersana Therapeutics, Inc. MRSN Director 2024-01-02 588,694 2024-01-02 9,595    Premium*  
            Regulus Therapeutics Inc. RGLS 10% Owner 0 2019-05-07 2,052,454    Premium*  
            Surface Oncology, Inc. SURF 10% Owner 2018-04-23 0 2018-04-23 3,312,877    Premium*  
            Rhythm Pharmaceuticals, Inc. RYTM 10% Owner 2017-10-10 0 2017-10-10 4,909,956    Premium*  
            Appian Corp APPN 10% Owner 2017-11-20 0 2018-02-13 2,031    Premium*  
            Elastic N.v. ESTC 10% Owner 2018-10-10 0 2018-10-10 2,197,503    Premium*  
            Genocea Biosciences, Inc. GNCA 10% Owner 2019-02-14 0 2019-06-24 7,225,676    Premium*  
            Trevi Therapeutics, Inc. TRVI 10% Owner 2019-05-09 0 2019-05-09 4,438,562    Premium*  
            Nightstar Therapeutics Plc NITE Director, 10% Owner 2019-06-07 0 2019-06-07 0    Premium*  
            Mirum Pharmaceuticals, Inc. MIRM 10% Owner 2019-07-22 0 2019-07-22 4,186,243    Premium*  
            Cloudflare, Inc. NET 10% Owner 2019-09-17 4,059,376 2019-09-17 0    Premium*  
            Novavax Inc NVAX Director 2023-06-10 43,800 0    Premium*  
            Enliven Therapeutics Ord Shs ELVN Director 2022-02-23 229,224 2022-02-10 0    Premium*  
* Premium Members only  

Records found :    221         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 7 of 9
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
MEDI Medimmune Inc Vice Chairman, CEO & President   •       •      –    2006-03-08 4 OE $2.75 $44,385 D/D 16,140 208,410 -
CASC Cascadian Therapeutics, I... 10% Owner   –       –       •   2018-02-20 4 OE $3.30 $5,999,400 I/I 1,818,000 10,882,574 0 -
GNCA Genocea Biosciences, Inc. 10% Owner   –       –       •   2019-06-24 4 B $3.50 $9,999,997 I/I 2,857,142 7,225,676 1.5 -
ARDX Ardelyx Inc Director   –       •       •   2018-05-25 4 A $4.00 $3,333,332 I/I 833,333 3,082,186 0 -
MRSN Mersana Therapeutics, Inc... Director   –       •       •   2019-03-05 4 B $4.00 $15,000,000 I/I 3,750,000 11,890,138 2.25 -
EPZM Epizyme, Inc. Director   –       •      –    2021-09-30 4 A $5.12 $23,757 D/D 4,640 169,185 0 -
MRSN Mersana Therapeutics, Inc... Director   –       •      –    2020-04-07 4 B $5.59 $3,010,768 D/D 538,599 538,599 2.39 %
TCON Tracon Pharmaceuticals, I... 10% Owner   –       –       •   2016-11-29 4 B $5.75 $4,999,999 I/I 869,565 2,758,039 1.5 -
ARDX Ardelyx Inc Director   –       •      –    2020-12-10 4 B $5.89 $1,000,841 D/D 170,000 417,284 2.39 %
ARDX Ardelyx Inc Director   –       •       •   2019-12-09 4 A $6.25 $2,500,000 I/I 400,000 3,482,186 0 -
ARDX Ardelyx Inc Director   –       •      –    2020-06-22 4 B $6.75 $31,525 D/D 4,673 106,313 2.39 %
ARDX Ardelyx Inc Director   –       •      –    2020-06-24 4 B $6.75 $489,862 D/D 72,598 178,911 2.39 %
ARDX Ardelyx Inc Director   –       •      –    2020-06-25 4 B $6.96 $476,040 D/D 68,373 247,284 2.39 %
SYBX Synlogic Inc 10% Owner   –       –       •   2015-10-06 4 B $7.00 $5,999,994 I/I 857,142 2,971,517 1.5 -
MEDI Medimmune Inc Vice Chairman, CEO & President   •       •      –    2007-03-19 4 OE $7.40 $765,900 D/D 103,500 422,116 0 -
MEDI Medimmune Inc Vice Chairman, CEO & President   •       •      –    2007-03-21 4 OE $7.40 $396,588 D/D 53,593 475,709 0 -
MEDI Medimmune Inc Vice Chairman, CEO & President   •       •      –    2007-03-23 4 OE $7.40 $957,479 D/D 129,389 605,098 0 -
EPZM Epizyme, Inc. Director   –       •      –    2021-03-26 4 B $7.80 $274,817 D/D 34,486 150,900 2.39 %
EPZM Epizyme, Inc. Director   –       •      –    2021-03-25 4 B $7.98 $225,283 D/D 28,231 116,414 2.39 %
EPZM Epizyme, Inc. Director   –       •      –    2021-06-30 4 A $8.31 $23,750 D/D 2,858 164,545 0 -
EPZM Epizyme, Inc. Director   –       •      –    2021-03-31 4 A $8.71 $23,752 D/D 2,727 153,627 0 -
ARDX Ardelyx Inc Director   –       •       •   2016-07-18 4 B $8.73 $13,333,338 I/I 1,527,301 2,665,519 2.25 -
EPZM Epizyme, Inc. Director   –       •       •   2016-01-12 4 B $9.00 $9,999,999 I/I 1,111,111 5,854,351 2.25 -
EPZM Epizyme, Inc. Director   –       •      –    2018-10-05 4 B $9.00 $3,750,003 I/I 416,667 6,471,018 2.1 -
SYBX Synlogic Inc 10% Owner   –       –       •   2018-01-26 4 A $9.75 $3,997,500 I/I 410,000 4,228,940 0 -
  221  Records found
  1   2   3   4   5   6   7  8   9      
  Page 7 of 9  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us